Axa S.A. Laboratory Corp Of America Holdings Transaction History

Axa S.A.

  • $32.3 Billion
  • Q3 2024

Shares

31 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024
SELL
$209.01 - $232.56 $418 - $465
-2 Reduced 0.12%
1,650 $360,000
Q4 2023

Jul 16, 2024
BUY
$197.69 - $227.29 $395 - $454
2 Added 0.12%
1,652 $375,000
Q4 2023

Feb 14, 2024
SELL
$197.69 - $227.29 $6.64 Million - $7.63 Million
-33,586 Reduced 95.31%
1,652 $375,000
Q3 2023

Nov 14, 2023
BUY
$201.05 - $221.7 $6.77 Million - $7.47 Million
33,690 Added 2176.36%
35,238 $7.08 Million
Q2 2023

Aug 14, 2023
SELL
$211.93 - $241.33 $3.07 Million - $3.5 Million
-14,490 Reduced 90.35%
1,548 $373,000
Q1 2023

May 15, 2023
SELL
$213.32 - $257.83 $13.8 Million - $16.6 Million
-64,533 Reduced 80.09%
16,038 $3.68 Million
Q4 2022

Feb 14, 2023
SELL
$203.72 - $248.97 $3.84 Million - $4.69 Million
-18,841 Reduced 18.95%
80,571 $19 Million
Q3 2022

Feb 14, 2023
BUY
$204.81 - $262.19 $1.86 Million - $2.38 Million
9,088 Added 10.06%
99,412 $20.4 Million
Q3 2022

Nov 14, 2022
BUY
$204.81 - $262.19 $1.86 Million - $2.38 Million
9,088 Added 10.06%
99,412 $20.4 Million
Q2 2022

Feb 14, 2023
SELL
$213.86 - $277.87 $16.6 Million - $21.5 Million
-77,550 Reduced 46.2%
90,324 $21.2 Million
Q2 2022

Aug 15, 2022
SELL
$213.86 - $277.87 $16.6 Million - $21.5 Million
-77,550 Reduced 46.2%
90,324 $21.2 Million
Q1 2022

Feb 14, 2023
BUY
$259.82 - $298.18 $17.8 Million - $20.4 Million
68,462 Added 68.87%
167,874 $44.3 Million
Q1 2022

May 13, 2022
BUY
$259.82 - $298.18 $13.4 Million - $15.4 Million
51,668 Added 44.46%
167,874 $44.3 Million
Q4 2021

Feb 14, 2022
BUY
$271.6 - $314.21 $12.6 Million - $14.6 Million
46,371 Added 66.4%
116,206 $36.5 Million
Q3 2021

Nov 15, 2021
BUY
$274.82 - $308.34 $7.97 Million - $8.94 Million
28,996 Added 71.0%
69,835 $19.7 Million
Q2 2021

Aug 13, 2021
SELL
$251.87 - $278.14 $149,862 - $165,493
-595 Reduced 1.44%
40,839 $11.3 Million
Q1 2021

May 14, 2021
BUY
$204.88 - $255.03 $942,448 - $1.17 Million
4,600 Added 12.49%
41,434 $10.6 Million
Q4 2020

Feb 12, 2021
SELL
$186.91 - $214.42 $1.7 Million - $1.95 Million
-9,076 Reduced 19.77%
36,834 $7.5 Million
Q3 2020

Nov 13, 2020
BUY
$167.03 - $201.3 $5.16 Million - $6.22 Million
30,900 Added 205.86%
45,910 $8.64 Million
Q2 2020

Aug 14, 2020
SELL
$113.31 - $182.44 $3.98 Million - $6.4 Million
-35,087 Reduced 70.04%
15,010 $2.49 Million
Q1 2020

May 15, 2020
BUY
$104.32 - $195.28 $2.32 Million - $4.35 Million
22,278 Added 80.08%
50,097 $6.33 Million
Q4 2019

Feb 18, 2020
BUY
$163.48 - $173.61 $851,240 - $903,987
5,207 Added 23.03%
27,819 $4.71 Million
Q3 2019

Nov 14, 2019
BUY
$159.77 - $178.1 $1.54 Million - $1.72 Million
9,669 Added 74.7%
22,612 $3.8 Million
Q2 2019

Aug 13, 2019
BUY
$144.16 - $172.9 $1.38 Million - $1.66 Million
9,599 Added 287.05%
12,943 $2.24 Million
Q1 2019

May 14, 2019
SELL
$123.7 - $156.3 $988,115 - $1.25 Million
-7,988 Reduced 70.49%
3,344 $512,000
Q4 2018

Feb 13, 2019
BUY
$120.82 - $174.09 $229,558 - $330,771
1,900 Added 20.14%
11,332 $1.43 Million
Q3 2018

Nov 08, 2018
SELL
$167.67 - $188.27 $653,913 - $734,253
-3,900 Reduced 29.25%
9,432 $1.64 Million
Q2 2018

Aug 13, 2018
SELL
$160.33 - $189.41 $10,421 - $12,311
-65 Reduced 0.49%
13,332 $2.39 Million
Q1 2018

May 14, 2018
BUY
$161.53 - $178.11 $452,284 - $498,708
2,800 Added 26.42%
13,397 $2.17 Million
Q4 2017

Feb 13, 2018
BUY
$147.99 - $163.95 $6,511 - $7,213
44 Added 0.42%
10,597 $1.69 Million
Q3 2017

Nov 13, 2017
BUY
$149.47 - $160.56 $1.58 Million - $1.69 Million
10,553
10,553 $1.59 Million

Others Institutions Holding LH

# of Institutions
95
Shares Held
1.94M
Call Options Held
0
Put Options Held
0
View Full List

About LABORATORY CORP OF AMERICA HOLDINGS

LH Quotes by TradingView
  • Ticker LH
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 89,600,000
  • Market Cap $20.6B
  • Description
  • Laboratory Corporation of America Holdings operates as a global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). It offers various tests,...
More about LH
Track This Portfolio

Track Axa S.A. Portfolio

Follow Axa S.A. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Axa S.A., based on Form 13F filings with the SEC.

News

Stay updated on Axa S.A. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email